IR@PKUHSC  > 北京大学精神卫生研究所
学科主题精神卫生
Pharmacokinetics and tolerability of paliperidone palmitate injection in Chinese subjects
Si, Tianmei1,2; Su, Yun′ ai1,2; Liu, Yi1,2; Zhang, Hongyan1,2; Li, Huafang3; Rui, Qing4; Shu, Liang1,2
关键词pharmacokinetics paliperidone palmitate Chinese
刊名HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
2014-03-01
DOI10.1002/hup.2388
29期:2页:203-210
收录类别SCI
文章类型Article
WOS标题词Science & Technology ; Social Sciences
类目[WOS]Clinical Neurology ; Pharmacology & Pharmacy ; Psychiatry ; Psychology
研究领域[WOS]Neurosciences & Neurology ; Pharmacology & Pharmacy ; Psychiatry ; Psychology
关键词[WOS]EXTENDED-RELEASE TABLETS ; SWITCHING STABLE PATIENTS ; ORAL ANTIPSYCHOTICS ; DOUBLE-BLIND ; SCHIZOPHRENIA ; SAFETY ; EFFICACY ; RISPERIDONE ; SCALE ; 6-WEEK
英文摘要

ObjectiveThe objective of this study was to characterize the pharmacokinetics of 25, 100, and 150mg equivalents (eq.) of paliperidone long-acting injection in Chinese subjects with schizophrenia.

MethodsThis was an open-label, randomized, parallel group, multicenter study. A total of 48 patients were randomized in a 1:1:1 ratio to one of three groups. Sequential blood samples were collected immediately before injection on day1 and up to 210days after the first injection. The plasma paliperidone concentrations were determined by a validated high-performance liquid chromatography/tandem mass spectrometry method.

ResultsA total of 47 patients received at least one injection of the study medication, and 43 completed the study. The pharmacokinetic (PK) parameters, such as time to maximum concentration, t1/2, and CL/F, were comparable across the three treatment groups (p=0.935, 0.349, and 0.794, respectively). The differences in maximum plasma concentration, AUC (035days), AUC (0-210days), and AUC (0-) were significant (p<0.001) and dose proportional. The inter-individual variation of PK parameters was large. The most frequent treatment-emergent adverse events were prolactin level increasing, injection site pain, tremor, dry mouth, and constipation.

ConclusionsThe pharmacokinetics of paliperidone palmitate are linear with respect to time in Chinese subjects with schizophrenia at injections from 25 to 150mg eq. Copyright (c) 2014 John Wiley & Sons, Ltd.

语种英语
WOS记录号WOS:000333015700012
资助机构Johnson &amp ; Johnson Pharmaceutical Research Development
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63960
专题北京大学精神卫生研究所
北京大学医学图书馆_采访编目部
北京大学精神卫生研究所_药理室
作者单位1.Peking Univ, Inst Mental Hlth, Dept Clin Psychopharmacol, Beijing 100191, Peoples R China
2.Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100191, Peoples R China
3.Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
4.Xian Janssen Pharmaceut Ltd, China R&D & Sci Affairs, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Si, Tianmei,Su, Yun&prime,ai,et al. Pharmacokinetics and tolerability of paliperidone palmitate injection in Chinese subjects[J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL,2014,29(2):203-210.
APA Si, Tianmei.,Su, Yun&prime.,ai.,Liu, Yi.,Zhang, Hongyan.,...&Shu, Liang.(2014).Pharmacokinetics and tolerability of paliperidone palmitate injection in Chinese subjects.HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL,29(2),203-210.
MLA Si, Tianmei,et al."Pharmacokinetics and tolerability of paliperidone palmitate injection in Chinese subjects".HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 29.2(2014):203-210.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Si, Tianmei]的文章
[Su, Yun&prime]的文章
[ai]的文章
百度学术
百度学术中相似的文章
[Si, Tianmei]的文章
[Su, Yun&prime]的文章
[ai]的文章
必应学术
必应学术中相似的文章
[Si, Tianmei]的文章
[Su, Yun&prime]的文章
[ai]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。